NDAC
This article was originally published in The Tan Sheet
Executive Summary
Committee will meet jointly with Pharmaceutical Science Advisory Committee's Drug Safety & Risk Management Subcommittee April 22, according to tentative advisory committee meeting dates posted on FDA's Web site Feb. 28. Although no agenda has been formally announced, acetaminophen and liver toxicity could be topic for discussion (1"The Tan Sheet" Feb. 18, 2002, p. 3). Additional NDAC meeting dates are April 23, June 21...